Nobel Prize winner Aaron Chekhanovo: The prospect of the development of malignant tumor drugs is bright

Jimu Journalist Liu Xun Wang Chenxi

On August 5th, the "2022 World Big Health Expo" was held at the Wuhan International Expo Center. In the afternoon of the same day, as an important part of the "Jianbo Fair", the "2022 World Big Health Academician Forum" was held online. Chinese and foreign academicians gathered in the cloud to talk about "big health". From different levels of major issues that affect people's health, theoretical research, cutting -edge technologies, etc., such as expressive wisdom and pragmatic strategies, bring you an academic feast of thinking collision and gathering wisdom.

Aaron Camero

The Nobel Prize winner and foreign academician of the Chinese Academy of Sciences Amaron Chekhanovo published the "Revolution of Personalized Medicine: Can we cure all diseases?" What is the price? "The keynote speech, he pointed out that in the face of the individualization of the same disease, we need to completely change our medical methods, abandon modeling and one -size -fits -cut drug treatment method, and develop the corresponding diseases according to the patient's specific conditions. He said that we were not treating diseases, but the disease of a well -known individual patient. In the live broadcast, he also mentioned that medical scientists have developed a lot of effective drugs for malignant tumors, "Especially the blood system malignant tumors, such as multiple osteoma, and other drugs under development. It can be said that in the future The prospect is bright. "

Expert business card:

Aaron Ciechanover, born in Israel, October 1, 1947. Israeli biochemist, surgeon, foreign academician of the National Academy of Sciences, foreign academicians of the National Medical College, foreign academicians of the American Academy of Arts and Sciences, Academician of the School of Humanities and Natural Sciences of Israel, and foreign academicians of the Chinese Academy of Sciences.

Aaron Chekhanovo graduated from the Hudsa Medical College of Hebrew in 1970 at the Hudsa Medical College of Hebrews, obtained a master's degree in science; in 1981, he received a PhD in Science from the Israeli Institute of Medicine; Senior lecturer (lifelong faculty); in 2002, he served as an outstanding research professor at the Israeli Institute of Technology; he was elected as a foreign academician of the Chinese Academy of Sciences in 2013. In 2004, he and Israel's scientist Avram Hershko and American scientist Irwin Rose discovered the protein degradation (an important mechanism of a protein degradation) to obtain Nobelkel Chemical award. He was also the first Israelist to win the Scientific Nobel Prize.

The main research field of Alon Chekhanovo is the pathogenesis of diseases, malignant tumors and neurodegenerative diseases, and protein degradation of pan -mediated protein.

- END -